IMMUNOVANT INC. - CO
29.40
07-十月-24 14:59:58
15 分钟延时
股票
-1.11
-3.64%
今日范围
28.92 - 30.58
ISIN
N/A
来源
NASDAQ
-
Immunovant Provides Update on Graves’ Disease Development Program
09 9月 2024 02:55:00 条件 Nasdaq GlobeNewswire
-
Immunovant to Host Graves’ Disease Program Update on September 9, 2024
05 9月 2024 05:30:00 条件 Nasdaq GlobeNewswire
-
06 8月 2024 15:05:01 条件 Nasdaq GlobeNewswire
-
29 5月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
Immunovant Awarded U.S. Patent for IMVT-1402
12 3月 2024 06:30:04 条件 Nasdaq GlobeNewswire
-
12 2月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
20 12月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
28 11月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Immunovant to Present at Upcoming Investor Conferences
13 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
09 11月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
02 10月 2023 15:52:02 条件 Nasdaq GlobeNewswire
-
Immunovant Announces Pricing of $450 Million Common Stock Financing
27 9月 2023 22:41:51 条件 Nasdaq GlobeNewswire
-
Immunovant Announces Proposed Offering of $300 Million of Common Stock
26 9月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
26 9月 2023 05:00:00 条件 Nasdaq GlobeNewswire
-
25 9月 2023 22:01:32 条件 Nasdaq GlobeNewswire
-
10 8月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
22 5月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
03 2月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th
07 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >